Physician profile
John Robert Foote, JR.
NPI 1326166265
$1,284.95
in general payments reported to CMS, 2019-2025
9 companies · $100 in 2025
The $100 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $113 · 2021: $149 · 2022: $160 · 2023: $175 · 2024: $250 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $525.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $812.50 | 2020-2025 | |
| Peter Brasseler Holdings, LLC | $250.52 | 2019 | |
| Patterson Companies, INC. | $111.90 | 2021-2022 | |
| Ultradent Products INC | $41.49 | 2019 | |
| Zimmer Biomet Holdings, INC. | $22.56 | 2019 | |
| Ortho Organizers, INC. | $12.29 | 2021 | |
| Voco America INC. | $11.88 | 2019 | |
| Philips North America LLC | $11.81 | 2019 | |
| Dash Medical Gloves LLC | $10.00 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Foote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.